AI in Pathology Market OverviewThe global AI in pathology market is undergoing rapid expansion, driven by transformative changes across diagnostic medicine and healthcare technology. The market is ...
The Print on MSN
Trained on Indian patients’ data, how an AI tool can improve breast & ovarian cancer diagnosis, treatment
The AI platform integrates pathology findings, imaging data, lab results and clinical history, and then analyses combined ...
The AI in cancer diagnostics market presents significant opportunities driven by advancements in AI and machine learning ...
US FDA approves expanded use of Agilent’s PD-L1 IHC 22C3 pharmDx on Dako Omnis in ESCC, TNBC, and gastric or gastroesophageal junction adenocarcinoma: Santa Clara, California Fr ...
DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for ...
Moving from pen and paper to a fully digitalised logistics solution is saving time and money for one of Australia's biggest ...
ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...
International momentum is evidenced by the 2026 symposium attracting participants from 73 countries, and highlighting OGM ...
While aggregate US funding volumes surged to historic highs, 88% of all deal value is concentrating in AI and critical ...
Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...
Advances in technology are transforming criminal justice, but without safeguards, they can also lead to wrongful convictions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results